

Andrew Colvett
Executive producer and longtime senior staffer for Charlie Kirk and Turning Point USA; provides organizational context and commentary about Charlie Kirk's legacy and TPUSA operations.
Top 3 podcasts with Andrew Colvett
Ranked by the Snipd community

61 snips
Sep 18, 2025 • 1h 14min
Megyn Kelly Hosts The Charlie Kirk Show - On Charlie's Legacy, Kimmel Sidelined, and What Comes Next | Ep. 1152
Walter Kirn, an author and cultural commentator, joins to discuss Jimmy Kimmel's indefinite suspension and the importance of media accountability. Mikey McCoy, Charlie Kirk's former chief of staff, reveals insights into Kirk's daily routines and the future direction of Turning Point USA. Andrew Colvett, executive producer, shares Charlie's leadership style and succession planning, emphasizing the organization's commitment to preserving his legacy. The conversation dives into the broader impact of Kirk's work on the conservative movement and civic engagement.

Sep 11, 2025 • 0sec
Episode 4770: Charlie Kirk: The America First Martyr
Join Andrew Colvett, Tyler Boyer, Jack Posobiec, and Dave Brat as they reminisce about Charlie Kirk's influential legacy following his tragic demise. They discuss the importance of faith in conservative leadership and the necessity of grassroots political activism. The conversation reflects on Kirk's impact on youth engagement and the challenges of maintaining conservative values in education. The guests also analyze the geopolitical landscape and urge listeners to reclaim America's foundational principles.

Nov 13, 2025 • 0sec
Episode 4924: The Punch List On Saving America; Next Direction Of MAHA
Andrew Colvett, co-host on the Charlie Kirk Show, shares insights on Turning Point's youth outreach initiatives and critical policy 'punch list' items like immigration reform. Political analyst Richard Barris analyzes campaign spending and the importance of a targeted ground game after recent Mid-Atlantic election losses. Documentary filmmaker Claire Dooley discusses the MAHA Summit, focusing on biotech discussions, genome sequencing ethics, and public health debates, emphasizing the need for transparency and informed consent in emerging technologies.


